Advertisement
Singapore markets closed
  • Straits Times Index

    3,290.70
    +24.75 (+0.76%)
     
  • Nikkei

    38,229.11
    +155.13 (+0.41%)
     
  • Hang Seng

    18,963.68
    +425.87 (+2.30%)
     
  • FTSE 100

    8,433.76
    +52.41 (+0.63%)
     
  • Bitcoin USD

    61,093.83
    -1,357.13 (-2.17%)
     
  • CMC Crypto 200

    1,262.01
    -96.00 (-7.06%)
     
  • S&P 500

    5,217.70
    +3.62 (+0.07%)
     
  • Dow

    39,489.32
    +101.56 (+0.26%)
     
  • Nasdaq

    16,324.18
    -22.08 (-0.14%)
     
  • Gold

    2,368.20
    +27.90 (+1.19%)
     
  • Crude Oil

    78.68
    -0.58 (-0.73%)
     
  • 10-Yr Bond

    4.5000
    +0.0510 (+1.15%)
     
  • FTSE Bursa Malaysia

    1,600.67
    -0.55 (-0.03%)
     
  • Jakarta Composite Index

    7,088.79
    -34.81 (-0.49%)
     
  • PSE Index

    6,511.93
    -30.53 (-0.47%)
     

Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 mln

April 24 (Reuters) - Laboratory service provider Labcorp said on Wednesday it will acquire Softbank-backed Invitae Corp's assets auctioned through a voluntary bankruptcy protection process, a few months after the genetic test maker filed for bankruptcy.

Labcorp will acquire all of the bankrupt firm's assets on a going concern basis for $239 million in cash consideration and other non-cash consideration, the companies said in separate statements.

In February, Invitae filed for voluntary Chapter 11 protection in a U.S. bankruptcy court and said that it intended to pursue a sale process.

Invitae's estimated assets were in the $500 million - $1 billion range, while its liabilities were in the $1 billion - $10 billion range, according to the bankruptcy filing. (Reporting by Chandni Shah in Bengaluru; Editing by Mrigank Dhaniwala)